Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANDU PHARMA vs MOREPEN LABS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANDU PHARMA MOREPEN LABS SANDU PHARMA/
MOREPEN LABS
 
P/E (TTM) x 48.8 28.2 172.8% View Chart
P/BV x 1.4 2.9 49.5% View Chart
Dividend Yield % 1.3 0.0 -  

Financials

 SANDU PHARMA   MOREPEN LABS
EQUITY SHARE DATA
    SANDU PHARMA
Mar-23
MOREPEN LABS
Mar-23
SANDU PHARMA/
MOREPEN LABS
5-Yr Chart
Click to enlarge
High Rs8655 156.9%   
Low Rs5024 212.5%   
Sales per share (Unadj.) Rs67.627.7 243.9%  
Earnings per share (Unadj.) Rs1.60.8 208.1%  
Cash flow per share (Unadj.) Rs2.11.3 161.8%  
Dividends per share (Unadj.) Rs0.750-  
Avg Dividend yield %1.10-  
Book value per share (Unadj.) Rs40.614.7 275.8%  
Shares outstanding (eoy) m9.66511.17 1.9%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.01.4 71.2%   
Avg P/E ratio x43.351.8 83.5%  
P/CF ratio (eoy) x32.330.1 107.3%  
Price / Book Value ratio x1.72.7 63.0%  
Dividend payout %47.60-   
Avg Mkt Cap Rs m65820,051 3.3%   
No. of employees `000NANA-   
Total wages/salary Rs m1111,547 7.2%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m65314,175 4.6%  
Other income Rs m361 5.3%   
Total revenues Rs m65714,237 4.6%   
Gross profit Rs m25795 3.1%  
Depreciation Rs m5279 1.9%   
Interest Rs m120 4.0%   
Profit before tax Rs m22558 4.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m7171 4.1%   
Profit after tax Rs m15387 3.9%  
Gross profit margin %3.85.6 67.8%  
Effective tax rate %31.430.6 102.5%   
Net profit margin %2.32.7 85.3%  
BALANCE SHEET DATA
Current assets Rs m2557,562 3.4%   
Current liabilities Rs m1393,212 4.3%   
Net working cap to sales %17.830.7 58.2%  
Current ratio x1.82.4 78.2%  
Inventory Days Days6518 357.2%  
Debtors Days Days268678 39.5%  
Net fixed assets Rs m2863,543 8.1%   
Share capital Rs m971,022 9.5%   
"Free" reserves Rs m2966,507 4.5%   
Net worth Rs m3927,529 5.2%   
Long term debt Rs m09 0.0%   
Total assets Rs m54211,105 4.9%  
Interest coverage x28.729.1 98.5%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.21.3 94.5%   
Return on assets %3.03.7 80.7%  
Return on equity %3.95.1 75.4%  
Return on capital %5.97.7 76.4%  
Exports to sales %039.9 0.0%   
Imports to sales %030.5 0.0%   
Exports (fob) Rs mNA5,657 0.0%   
Imports (cif) Rs mNA4,324 0.0%   
Fx inflow Rs m05,657 0.0%   
Fx outflow Rs m04,444 0.0%   
Net fx Rs m01,213 0.0%   
CASH FLOW
From Operations Rs m2-912 -0.2%  
From Investments Rs m5-465 -1.2%  
From Financial Activity Rs m61,435 0.4%  
Net Cashflow Rs m1359 22.8%  

Share Holding

Indian Promoters % 42.9 38.2 112.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 4.3 0.2%  
FIIs % 0.0 2.1 -  
ADR/GDR % 0.0 0.0 -  
Free float % 57.1 61.8 92.4%  
Shareholders   10,021 304,289 3.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANDU PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on SANDU PHARMA vs MOREPEN LABS

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

SANDU PHARMA vs MOREPEN LABS Share Price Performance

Period SANDU PHARMA MOREPEN LABS S&P BSE HEALTHCARE
1-Day -0.45% 0.26% 1.18%
1-Month -15.08% -14.25% -0.75%
1-Year 9.73% 70.98% 61.82%
3-Year CAGR 19.30% 9.94% 18.16%
5-Year CAGR 21.14% 18.97% 19.79%

* Compound Annual Growth Rate

Here are more details on the SANDU PHARMA share price and the MOREPEN LABS share price.

Moving on to shareholding structures...

The promoters of SANDU PHARMA hold a 42.9% stake in the company. In case of MOREPEN LABS the stake stands at 38.2%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of SANDU PHARMA and the shareholding pattern of MOREPEN LABS.

Finally, a word on dividends...

In the most recent financial year, SANDU PHARMA paid a dividend of Rs 0.8 per share. This amounted to a Dividend Payout ratio of 47.6%.

MOREPEN LABS paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of SANDU PHARMA, and the dividend history of MOREPEN LABS.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.